Luca Tonella
- FISIOPATOLOGIA MEDICA
- Dottorato: 36° ciclo
- Dipartimento di Scienze Mediche
- Matricola: 791644
Contatti
- 3462880356
- luca.tonella@unito.it
- Via Cherasco 23, 1° Piano, Laboratorio di immunopatologia cutanea
- https://dott-fisiopatologia.campusnet.unito.it/do/studenti.pl/Show?791644
- VCard contatti
- QRcode contatti
Supervisore
Franco VeglioAttività di ricerca
The first step of the project will be the characterization of primary melanoma tumour, using the Illumina TSO500 panel. The panel is able to evaluate more than 500 genes involved in tumorigenesis, immunity and microenvironment. Next, we will study liquid biopsies of patients treated in adjuvant therapy, with the aim to follow the disease over time and predict the risk of relapse/progression.
Arese V et al. |
Autoimmune connective tissue diseases and pregnancy. |
Ribero S et al. |
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real‐life Italian tertiary centre experience |
Bossi P et al. |
Are fusion transcripts in relapsed/metastatic head and neck cancer patients predictive of response to anti-EGFR therapies? |
Quaglino P et al. |
Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient |
De Cecco, L et al. |
Dissecting heterogeneity and molecular mechanisms involved in paranasal sinus cancer |
Bossi P et al. |
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma |
Quaglino P et al. |
Correlation between CT scan findings at 3 and 6 months and pattern of response, progression-free survival and overall survival in advanced metastatic melanoma patients treated by anti-PD1 monotherapy: a single institution retrospective study |
Tonella L et al. |
Gene expression signatures for head and neck cancer patient stratification: are results ready for clinical application? |
Quaglino P et al. |
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome |
Quaglino P et al. |
Metastatic melanoma treatment with checkpoint inhibitors in the COVID‐19 era: experience from an Italian skin cancer unit |
Alfieri S et al. |
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma |
Barreiro-Capurro A et al. |
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study |
Quaglino P et al. |
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
- 2021_UNITO-POLITO CONFERENCE SERIES IN CANCER. NANOSCIENCE IN CANCER IMMUNOTHERAPY